Cardiovascular stents - Biomaterials and Devices for the Circulatory System - page 206

LEWIS AL, TOLHURST LA and STRATFORD PW. Analysis of a phosphorylcholine-based
polymer coating on a coronary stent pre- and post-implantation. Biomaterials
2002; 23 (7): 1697-1706.
LIU MW, ROUBIN GS and KING SB. Restenosis after coronary angioplasty: potential
biologic determinants and role of intimal hyperplasia. Circulation 1989; 74 :
1374-1387.
LLOYD A, OLIVIER G, STANDEN G, SANTIN M and MEIKLE S. Patent WO/2008/068531,
Biomaterial with functionalised surfaces, 2008.
LOWE HC, OESTERLE SP and KHACHIGIAN LM. Coronary in-stent retenosis: current status
and future strategies. J Am Coll Cardiol 2002; 39 : 183-193.
LUI HC, CHANG WHS, LIN KH, TSUANG YH and SUN JS. Cytokine and prostaglandin
E-2 release from leukocytes in response to metal ions derived from
different prosthetic materials: an in vitro study. Artifi cial Organs 1999; 23 :
1099-1106.
MAGUIRE PD, MCLAUGHLIN JA, OKPALUGO TIT, LEMONINE P, PAPAKONSTANTINOU P,
MCADAMS ET, NEEDHAM M, OGWU AA, BALL M and ABBAS GA. Mechanical stability,
corrosion performance and bioresponse of amorphous diamond-like carbon for
medical stents and guidewires. Diamond Related Mater 2005; 14 : 1277-1288.
MALIK N, GUNN J, SHEPHERD L, CROSSMAN DC, CUMBERLAND DC and HOLT CM. Phosphor-
ylcholine-coated stents in porcine coronary arteries: in vivo assessment of bio-
compatibility . J Invasive Cardiol 2001; 13 (3): 193-201.
MAURI L, O'MALLEY AJ, POPMA JJ, MOSES JW, LEON MB, HOLMES DR, TEIRSTEIN PS, CUTLIP
DE, DONAHOE D and KUNTZ RE. Comparison of thrombosis and restenosis risk from
stent length of sirolimus-eluting stent versus bare metal stents. Am J Card 2005;
95 : 1140-1145.
MAURI L, HSIEH WH, MASSARO JM, HO KK, D'AGOSTINO R and CUTLIP DE. Stent thrombosis
in randomized clinical trials of drug eluting stents. N Engl J Med 2007; 356 :
1020-1029.
MEIRELES GCX, DE ABREU LM, DA CRUZ FORTE AA, SUMITA MK, SUMITA JH and ALIAGA J.
Randomized comparative study of diamond-like carbon coated stainless steel
stent versus uncoated stent implantation in patients with coronary artery disease.
Arch Bras Cardiol 2007; 88 (4): 343-347.
MEHILLI J, KASTRATI A, WESSSELY R, DIBRA A, HAUSLEITER J, JASCHKE B, DIRSCHINGER J
and SCHÖMIG A. Intracoronary stenting and angiographic restenosis - test equiva-
lence between 2 drug-eluting stents (ISAR-TEST) trials investigators.
Randomised trial of a nonpolymer-based rapamycin-eluting stent versus a
polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
Circulation 2006; 113 (2): 273-279.
MIGLIONICO M, PATTI G, D'AMBROSIO A and DI SCIASCIO G. Percutaneous coronary
intervention utilizing a new endothelial progenitor cells antibody-coated stent: a
prospective single-centre registry in high-risk patients. Cathet Cardiovasc Interv
2008; 71 (5): 600-604.
MINTZ GS, POPMA JJ, PICHARD AD, KENT KM, SALTER LF, WONG SC, HONG MK, KOVACH JA
and LEON MB. Arterial remodelling after coronary angioplasty: a serial intravas-
cular ultrasound study. Circulation 1996; 94 : 35-43.
NAKANO K, EGASHIRA K, MASUDA S, FUNAKOSHI K, ZHAO G, KIMURA S, MATOBA T, SUEISHI
K, ENDO Y, KAWASHIMA Y, HARA K, TSUJIMOTO H, TOMINAGA R and SUNAGAWA K.
Formulation of nanoparticle-eluting stents by a cationic electrodeposition
coating technology: effi cient nano-drug delivery via bioabsorbable polymeric

￿ ￿ ￿ ￿ ￿